This notion is supported by clinical findings as DA antagonists ameliorate and DA stimulants exacerbate tics, respectively.75, 76 In line, DAT-tg rats display a general decrease in DA levels and increase in DA turnover due to DAT overexpression. Here, SLC6A3 is linked to tic disorder.